COMET stands for Comparing an Operation to Monitoring, with or without Endocrine Therapy, for low-risk DCIS.
The COMET Study is being conducted across the United States to compare two treatment approaches for low-risk DCIS: Active Monitoring and Surgery.
The COMET study is needed because these treatment approaches have not been compared directly before in patients with low-risk DCIS.
The COMET Study enrolled 995 women with low-risk DCIS at 100 sites throughout the US.
In December 2024, the initial (2-year) results of the COMET Study (clinical and patient-reported outcomes) were presented at the San Antonio Breast Cancer Symposium and published in Journal of the American Medical Association (JAMA) and JAMA Oncology! Please click on the links below to see these exciting results!
Shelley Hwang
Principal Investigator
Ann Partridge
Co-Principal Investigator
Alastair Thompson
Co-Principal Investigator
Elizabeth Frank
Lead Patient Advocate
Deborah Collyar
Patient Advocate
Donna Pinto
Patient Advocate
Desiree Basila
Patient Advocate
Terry Hyslop
Statistician
Thomas Lynch
Project Manager
